Moderators: T. Boemers, P. Lopez-Pereira


S04-24 (O)

UROLOGIC UPDATER OF PATIENTS WHO HAVE UNDERGONE FETAL REPAIR OF THEIR MYELOMENINGOCELE

Michael CARR
Children's Hospital of Philadelphia, Urology, Philadelphia, USA


S04-25 (PP)

PREDISPOSING FACTORS FOR THE DEVELOPMENT OF NEUROGENIC BLADDER IN PATIENTS WITH ANORECTAL MALFORMATIONS

Luis BRAGA, Maria H DEL-VALLE, Michael C. WALLIS, Wallid FARHAT, Darius BAGLI, Tony KHOURY and Joao L PIPPI SALLE
Hospital for Sick Children, Pediatric Urology, Toronto, CANADA


S04-26 (PP)

WHAT IS THE NEED OF URODYNAMICS IN CHILDREN WITH ANORECTAL MALFORMATIONS?

Helena BORG 1, Gundela HOLMDAHL 2, Ingrid OLSSON 3 and Ulla SILLÉN 2
1- Queen Silvia Childrens hospital, Pediatric Surgery, Gothenburg, SWEDEN
2- Queen Silvia Childrens hospital, Dept of Pediatric Surgery, Gothenburg, SWEDEN
3- Queen Silvia Childrens hospital, Dept of Pediatric Neurology, Gothenburg, SWEDEN


S04-27 (O)

THE CONTRACTILE PROPERTIES OF HUMAN PAEDIATRIC DETRUSOR SMOOTH MUSCLE IN PATIENTS WITH NEUROPATHIC BLADDER

Navroop JOHAL 1, Chris FRY 2 and Peter CUCKOW 1
1- Great Ormond Street Hospital, Department of Urology, London, UNITED KINGDOM
2- Institute of Urology & Nephrology, Division of Applied Physiology, London, UNITED KINGDOM


S04-28 (PP)

RENAL DETERIORATION IN THE ABSENCE OF VESICOURETERAL REFLUX IN MYELODYSPLASTIC PATIENTS

Zafer DOKUMCU, S Kerem OZEL, Cisem AKYILDIZ, Ali AVANOGLU and Ibrahim ULMAN
Ege University Faculty of Medicine, Paediatric Urology, Izmir, TURKEY


S04-29 (PwP)

PEDIATRIC NON-COMPLIANT NEUROGENIC BLADDER REFRACTORY TO ORAL OXYBUTYNIN: IS IT WORTHWHILE ADDING INTRAVESICAL OXYBUTININ?

Luis GUERRA 1, Gaayana RAJU 1, Julie MILKS 2, Manchun FANG 3, John PIKE 1 and Michael LEONARD 1
1- University of Ottawa - Children's Hospital of Eastern Ontario, Pediatric Urology, Ottawa, CANADA
2- University of Ottawa - Children's Hospital of Eastern Ontario, Urodynamics, Ottawa, CANADA
3- CHEO Research Institute, Biostatistics, Ottawa, CANADA


S04-30 (PP)

DEVELOPMENT OF URODYNAMICS AFTER UNTETHERING IN CHILDREN WITH MYELOMENINGOCELE

Kate ABRAHAMSSON 1, Ingrid OLSSON 2 and Ulla SILLÉN 1
1- The Queen Silvia Children's Hospital, Pediatric Urology, Göteborg, SWEDEN
2- The Queen Silvia Children's Hospital, Pediatrc Nephrology, Göteborg, SWEDEN


S04-31 (PP)

ARTIFICIAL URINARY SPHINCTER: 11-YEAR EXPERIENCE IN CHILDREN WITH NEUROPATHIC BLADDERS

Pedro LOPEZ-PEREIRA 1, Ivan SOMOZA 2, Mj MARTINEZ-URRUTIA 1, Roberto LOBATO 1, Ane ANDRES 1 and Enrique JAUREGUIZAR 1
1- UNIVERSITY HOSPITAL LA PAZ, Pediatric Urology, Madrid, SPAIN
2- Juan Canalejo Hospital, Pediatric Urology, Coruña, SPAIN


S04-32 (PP)

INFLUENCE OF TYPE OF CONDUIT AND SITE OF IMPLANTATION ON THE OUTCOME OF CATHETERIZABLE URINARY CONTINENT CHANNELS (CCC)

Lisandro PIAGGIO, Susan MYERS, T.Ernesto FIGUEROA, Julia BARTHOLD and Ricardo GONZALEZ
A I Dupont Hospital for Children, Urology, Wilmington, USA


S04-33 (O)

EPIGENETIC THERAPY FOR THE REVERSAL OF ABNORMAL GENE FUNCTION IN NEUROGENIC BLADDERS

Steve HODGES 1, Steve BLAHA 2, Jason Hipp HIPP 1, Nilamadhab MISHRA 2, George CHRIST 3, James YOO 3 and Anthony ATALA 1
1- Wake Forest University School of Medicine, Urology, Winston-Salem, USA
2- Wake Forest University School of Medicine, Rheumatology, Winston-Salem, USA
3- Wake Forest University School of Medicine, Institue of Regenerative Medicine, Winston-Salem, USA


Abbreviations:
O = Oral
PP = Poster
PwP = Poster without presentation
V = Video